[
    [
        {
            "time": "",
            "original_text": "白雲山(00874.HK)收到牛磺酸顆粒等21個藥品再註冊批件",
            "features": {
                "keywords": [
                    "白雲山",
                    "藥品",
                    "牛磺酸顆粒",
                    "再註冊批件"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山(00874.HK)收到牛磺酸顆粒等21個藥品再註冊批件",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "白雲山(600332.SH)：收到牛磺酸顆粒等21個藥品的藥品再註冊批件",
            "features": {
                "keywords": [
                    "白雲山",
                    "藥品",
                    "牛磺酸顆粒",
                    "再註冊批件"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山(600332.SH)：收到牛磺酸顆粒等21個藥品的藥品再註冊批件",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-07-07",
            "original_text": "【廣藥集團小公募】不超22億/3+2年（2.50%-3.80%）/中誠信AAA/AAA/上交所/暫定7月7日簿記",
            "features": {
                "keywords": [
                    "廣藥集團",
                    "小公募",
                    "債券",
                    "利率",
                    "簿記"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫藥",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【廣藥集團小公募】不超22億/3+2年（2.50%-3.80%）/中誠信AAA/AAA/上交所/暫定7月7日簿記",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]